Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis

Michael J. Wagner, Seth M. Pollack, Lee D. Cranmer, Matthew J. Thompson, Shannon Maxwell, Stephanie Wright, Ali R. Khaki, Margaret M. Madeleine, Petros Grivas, Nicole M. Kuderer, Gary H. Lyman, Elizabeth T. Loggers

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24–69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6–41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20–62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.

Original languageEnglish (US)
Pages (from-to)315-320
Number of pages6
JournalCancer Investigation
Volume39
Issue number4
DOIs
StatePublished - 2021
Externally publishedYes

Keywords

  • cohort Study
  • COVID-19
  • Sarcoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis'. Together they form a unique fingerprint.

Cite this